Preparing for HIV pre-exposure prophylaxis: Lessons learned from post-exposure prophylaxis

American Journal of Preventive Medicine

Volumn 44, Issue 1 SUPPL. 2, 2013, Pages

  Cohen, Stephanie E ^a   Liu, Albert Y ^a   Bernstein, Kyle T ^a   Philip, Susan ^a  

^a SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;

ARTICLE; HEALTH CARE COST; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; OCCUPATIONAL EXPOSURE; ORAL SEXUAL CONTACT; PATIENT COMPLIANCE; POST EXPOSURE PROPHYLAXIS; PRE EXPOSURE PROPHYLAXIS; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK REDUCTION; SEROCONVERSION; SEXUALLY TRANSMITTED DISEASE; UNITED STATES;

EID: 84871817698     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2012.09.036     Document Type: Review

References (44)

1. R.J. Black Animal studies of prophylaxis Am J Med 102 5B 1997 39 44
2. C.C. Tsai, P. Emau, K.E. Follis Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment J Virol 72 5 1998 4265 4273
3. D.M. Cardo, D.H. Culver, C.A. Ciesielski A case-control study of HIV seroconversion in health care workers after percutaneous exposure CDC Needlestick Surveillance Group N Engl J Med 337 21 1997 1485 1490
4. R.C. Merchant, K.H. Mayer, C.A. Browning Development of guidelines on nonoccupational HIV postexposure prophylaxis for the state of Rhode Island Public Health Rep 119 2 2004 136 140
5. J. Myles, J.D. Bamberger Offering HIV prophylaxis following sexual assault: recommendations for the state of California 2001 California HIV Postexposure Prophylaxis after Sexual Assault Task Force San Francisco CA
6. J.O. Kahn, J.N. Martin, M.E. Roland Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study J Infect Dis 183 5 2001 707 714
7. D.K. Smith, L.A. Grohskopf, R.J. Black Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the U.S.: recommendations from the U.S. Department of Health and Human Services MMWR Recomm Rep 54 RR-2 2005 1 20
8. P. Benn, M. Fisher, R. Kulasegaram UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure Int J STD AIDS 22 12 2011 695 708
9. J. Almeda, J. Casabona, B. Simon Proposed recommendations for the management of HIV post-exposure prophylaxis after sexual, injecting drug or other exposures in Europe Euro Surveill 9 6 2004 35 40
10. Australasian Society for HIV Medicine (ASHM) National guidelines for post-exposure prophylaxis after non-occupational exposure to HIV www.ashm.org.au/images/publications/guidelines/2007nationalnpepguidelines2.pdf 2007
11. R.M. Grant, J.R. Lama, P.L. Anderson iPrEx Study Team Preexposure chemoprophylaxis for HIV prevention in men who have sex with men N Engl J Med 363 27 2010 2587 2599
12. J.M. Baeten, D. Donnell, P. Ndase Partners PrEP Study Team Antiretroviral prophylaxis for HIV prevention in heterosexual men and women N Engl J Med 367 5 2012 399 410
13. M.C. Thigpen, P.M. Kebaabetswe, L.A. Paxton TDF2 Study Group N Engl J Med 367 5 2012 423 434
14. CDC Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men MMWR Morb Mortal Wkly Rep 60 3 2011 65 68
15. K.H. Mayer, M.J. Mimiaga, D. Cohen Tenofovir DF plus lamivudine or emtricitabine for nonoccupational postexposure prophylaxis (NPEP) in a Boston Community Health Center J Acquir Immune Defic Syndr 47 4 2008 494 499
16. K.H. Mayer, M.J. Mimiaga, M. Gelman, C. Grasso Raltegravir, tenofovir DF, and emtricitabine for postexposure prophylaxis to prevent the sexual transmission of HIV: safety, tolerability, and adherence J Acquir Immune Defic Syndr 59 4 2012 354 359
17. S.A. Mehta, R. Silvera, K. Bernstein, R.S. Holzman, J.A. Aberg, D.C. Daskalakis Awareness of post-exposure HIV prophylaxis in high-risk men who have sex with men in New York City Sex Transm Infect 87 4 2011 344 348
18. A.Y. Liu, P.V. Kittredge, E. Vittinghoff Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men J Acquir Immune Defic Syndr 47 2 2008 241 247
19. D.S. Krakower, M.J. Mimiaga, J.G. Rosenberger Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an Internet social networking site PLoS One 7 3 2012 e33119
20. R.J. Landovitz, K.B. Combs, J.S. Currier Availability of HIV postexposure prophylaxis services in Los Angeles County Clin Infect Dis 48 11 2009 1624 1627
21. I.B. Zablotska, G. Prestage, M. Holt Australian gay men who have taken nonoccupational postexposure prophylaxis for HIV are in need of effective HIV prevention methods J Acquir Immune Defic Syndr 58 4 2011 424 428
22. D.A. MacKellar, L.A. Valleroy, G.M. Secura Perceptions of lifetime risk and actual risk for acquiring HIV among young men who have sex with men AIDS Behav 11 2 2007 263 270
23. M.J. Mimiaga, H. Goldhammer, C. Belanoff, A.M. Tetu, K.H. Mayer Men who have sex with men: perceptions about sexual risk, HIV and sexually transmitted disease testing, and provider communication Sex Transm Dis 34 2 2007 113 119
24. M. Schechter, R.F. do Lago, A.B. Mendelsohn, R.I. Moreira, L.H. Moulton, L.H. Harrison Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV J Acquir Immune Defic Syndr 35 5 2004 519 525
25. T. Khawcharoenporn, S. Kendrick, K. Smith HIV risk perception and preexposure prophylaxis interest among a heterosexual population visiting a sexually transmitted infection clinic AIDS Patient Care STDs 26 4 2012 222 233
26. M.S. Cohen, Y.Q. Chen, M. McCauley HPTN 052 Study Team Prevention of HIV-1 infection with early antiretroviral therapy N Engl J Med 365 6 2011 493 505
27. D. Rey, M.K. Bendiane, A.D. Bouhnik, J. Almeda, J.P. Moatti, M.P. Carrieri Physicians' and patients' adherence to antiretroviral prophylaxis after sexual exposure to HIV: results from South-Eastern France AIDS Care 20 5 2008 537 541
28. L. Bentz, P. Enel, B. Dunais Evaluating counseling outcome on adherence to prophylaxis and follow-up after sexual HIV-risk exposure: a randomized controlled trial AIDS Care 22 12 2010 1509 1516
29. S. Day, A. Mears, K. Bond, R. Kulasegaram Post-exposure HIV prophylaxis following sexual exposure: a retrospective audit against recent draft BASHH guidance Sex Transm Infect 82 3 2006 236 237
30. G.J. Sonder, J.M. Prins, R.M. Regez Comparison of two HIV postexposure prophylaxis regimens among men who have sex with men in Amsterdam: adverse effects do not influence compliance Sex Transm Dis 37 11 2010 681 686
31. Anderson PL, Liu AY, Buchbinder SP, et al. Intracellular tenofovir-DP concentrations associated with PrEP efficacy in MSM from iPrEx. Proceedings of the 19th Conference on Retroviruses and Opportunistic Infections (CROI); 2012; Seattle, WA
32. L. Van Damme, A. Corneli, K. Ahmed FEM-PrEP Study Group N Engl J Med 367 5 2012 411 422
33. Liegler T, Abdel-Mohsen M, Mehotra M, et al. Drug resistance and minor drug resistant variants in iPrEx. Proceedings of the 18th Conference on Retroviruses and Opportunistic Infections; 2011; Boston, MA
34. S.A. Golub, D. Operario, P.M. Gorbach Pre-exposure prophylaxis state of the science: empirical analogies for research and implementation Curr HIV/AIDS Rep 7 4 2010 201 209
35. M.M. Cassell, D.T. Halperin, J.D. Shelton, D. Stanton Risk compensation: the Achilles' heel of innovations in HIV prevention? BMJ 332 7541 2006 605 607
36. J.N. Martin, M.E. Roland, T.B. Neilands Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior AIDS 18 5 2004 787 792
37. J. Richens, S.G. Edwards, S.T. Sadiq Can the promotion of post-exposure prophylaxis following sexual exposure to HIV (PEPSE) cause harm? Sex Transm Infect 81 3 2005 190 191 discussion 191-2
38. L.A. Eaton, S. Kalichman Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies Curr HIV/AIDS Rep 4 4 2007 165 172
39. D. Donnell, M.J. Mimiaga, K. Mayer, M. Chesney, B. Koblin, T. Coates Use of non-occupational post-exposure prophylaxis does not lead to an increase in high risk sex behaviors in men who have sex with men participating in the EXPLORE trial AIDS Behav 14 5 2010 1182 1189
40. I.M. Poynten, F. Jin, L. Mao Nonoccupational postexposure prophylaxis, subsequent risk behaviour and HIV incidence in a cohort of Australian homosexual men AIDS 23 9 2009 1119 1126
41. J. Heuker, G.J. Sonder, I. Stolte, R. Geskus, A. van den Hoek High HIV incidence among MSM prescribed postexposure prophylaxis, 2000-2009: indications for ongoing sexual risk behaviour AIDS 26 4 2012 505 512
42. S.A. Golub, W. Kowalczyk, C.L. Weinberger, J.T. Parsons Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men J Acquir Immune Defic Syndr 54 5 2010 548 555
43. Irvin R, Liu AY, Kroboth L, et al. Risk compensation and pre-exposure prophylaxis (PrEP): a post-iPrEx survey of U.S. men who have sex with men (MSM). Proceedings of the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; 2011; Rome, Italy.
44. B.A. Koblin, G. Mansergh, V. Frye Project MIX Study Team Condom-use decision making in the context of hypothetical pre-exposure prophylaxis efficacy among substance-using men who have sex with men: Project MIX J Acquir Immune Defic Syndr 58 3 2011 319 327